GS
KLRS

Gilead Sciences’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Gilead Sciences’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$848K Sell
317,789
-405,484
-56% -$1.08M 0.07% 12
2025
Q1 		$5.81M Hold
723,273
– – 0.49% 9
2024
Q4 		$6.99M Buy
+723,273
New +$6.99M 0.45% 10